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Abstract 43 
Background: In Scotland, the uptake of clinic-based breast (72%) and cervical (73%) screening 44 
is higher than home-based colorectal screening (~60%). To inform new approaches to increase 45 
uptake of colorectal screening, we compared the perceptions of colorectal screening among 46 
women with different screening histories. 47 
Method: We purposively sampled women with different screening histories to invite to semi-48 
structured interviews: i) participated in all; ii) participated in breast and cervical but not 49 
colorectal (‘colorectal-specific non-participants’); iii) participated in none. To identify the 50 
sample we linked the data for all women eligible for all three screening programmes in 51 
Glasgow, Scotland (aged 51-64 years; n=68,324). Interviews covered perceptions of cancer, 52 
screening, and screening decisions. Framework Method was used for analysis.  53 
Results: Of the 2,924 women invited, 86 expressed an interest, and 59 were interviewed. The 54 
three groups’ perceptions differed, with the colorectal-specific non-participants expressing 55 
that: i) treatment for colorectal cancer is more severe than for breast or cervical cancer; ii) 56 
colorectal symptoms are easier to self-detect than breast or cervical symptoms; iii) they 57 
worried about completing the test incorrectly; and iv) the colorectal test could be more easily 58 
delayed or forgotten than breast or cervical screening. 59 
Conclusions: Our comparative approach suggested targets for future interventions to 60 
increase colorectal screening uptake including: i) reducing fear of colorectal cancer 61 
treatments; ii) increasing awareness that screening is for the asymptomatic; iii) increasing 62 
confidence to self-complete the test; and iv) providing a suggested deadline and/or additional 63 
reminders.  64 
  65 
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BACKGROUND 66 
Colorectal cancer (CRC) is the second leading cause of cancer death worldwide.[1] CRC 67 
screening by faecal occult blood test (FOBt) can reduce deaths.[2] In Scotland, since 2007, 68 
people aged 50-74 have been mailed a self-complete FOBt every two years as part of the 69 
Scottish Bowel Screening Programme. The FOBt requires people to collect two samples from 70 
each of three separate bowel motions and to mail their completed kit for processing. Women 71 
in Scotland are also invited to attend a pre-arranged appointment for breast screening using 72 
mammography and to make an appointment for cervical screening using the Pap smear (Table 73 
1). All three screening tests are offered at no cost to participants through the National Health 74 
Service. Uptake of screening is 77% for cervical, 72% for breast but only 59% for colorectal 75 
among women aged 50 and over.[3-5] Screening uptake rates show similar patterns in 76 
Australia and the US with uptake of CRC screening lagging behind the participation rates of 77 
breast and cervical screening.[6, 7] 78 
Table 1 
Invitation procedures in the Scottish cancer screening programmes 
 
 Screening programme 
 
 Breast screening by 
mammography 
 
Cervical screening by 
smear test 
CRC screening by faecal occult 
blood test 
Pre-
notification 
 
None 
 
None 
 
2 weeks prior to invitationa 
Invitation 
(mailed) 
Within 3 years after 50th 
birthday 
Until 70th birthday 
After 70th birthday on 
request 
Before June 2016: 
After 20th birthday 
Until 60th birthday 
From June 2016: 
After 25th birthday 
Until 65th birthday 
 
From 50th birthday 
Until 75th birthday 
After 75th birthday on request 
Reminder 
(mailed) 
Reminder at 3 days 
following non-attendance 
Reminders at 3 months 
and at 6 months after 
the invitation 
 
Reminder at 6 weeks after the 
invitation 
Screening 
interval 
Every 3 years Aged 25-49: every 3 
years 
Aged 50-64: every 5 
years 
 
Every 2 years 
Notes. apre-notification letters for CRC screening ceased in February 2015. 
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Reasons for the low uptake of CRC screening include lack of awareness, feeling healthy, 79 
negative views of cancer (fear, fatalism), negative attitudes towards colorectal tests, lack of 80 
motivation including other health concerns, and cultural, gender and socioeconomic 81 
influences.[8-11] Many of these potential barriers also apply to breast and cervical 82 
screening,[12] so it is unclear why CRC screening uptake should remain considerably lower. 83 
There have been few comparisons of barriers across these three screening modalities.[13, 14] 84 
We identified only one study that directly compared barriers to breast, cervical and CRC 85 
screening uptake among women eligible for all three tests.[15] This British self-report survey 86 
of 890 women found that among those who participated in breast and cervical but not 87 
colorectal programmes, 23% reported not liking the idea of CRC screening test and 18% said 88 
they ‘haven’t got round to it, but intend to take part’ as explanations for non-participation in 89 
CRC screening.[15] These explanations relate to both motivational influences such as dislike 90 
of the test, and volitional aspects of ‘not getting round to it’,[16] the latter being particularly 91 
salient for CRC screening which, unlike breast and cervical screening, is self-completed at 92 
home. Our study adds to those data in three main respects. Firstly, rather than using self-93 
reported data of screening history, we linked cancer screening uptake data for the breast, 94 
cervical and CRC screening programmes for the complete population of Glasgow, Scotland—95 
a socioeconomically diverse region with low overall screening uptake. Using this linked 96 
dataset, we identified women with three different screening histories: i) participated in all 97 
programmes; ii) participated in breast and cervical but not colorectal programmes; and iii) did 98 
not participate in any programme. Secondly, we invited women across these three groups to 99 
an individual in-depth interview, rather than a questionnaire, to provide the opportunity for 100 
women to speak at length about their perceptions and experiences of cancer screening.  101 
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Thirdly, we organised our findings using the route MAP approach which is a useful tool to 102 
summarise the central tenets of multiple models of behaviour change [17]. The MAP describes 103 
three routes to behaviour: i) Motivation—strategies that increase and sustain motivation (e.g. 104 
information about the behaviour, reassurance); Action-on-motivation—strategies that 105 
strengthen and elaborate skills needed to translate motivations into action (e.g. setting 106 
behavioural goals, action and coping planning); and Prompted or cued routes—strategies that 107 
support behaviour change without the continuous cognitive effort required by the Motivation 108 
and Action-on-motivation routes (e.g. prompt, change the environment to facilitate the target 109 
behaviour). The MAP approach therefore provides a theoretically informed framework to 110 
identify targets for intervention.  111 
The present study was designed to 1) identify why women (who are eligible for all three types 112 
of screening) choose to participate in breast and cervical screening but not CRC screening, and 113 
2) gain insight into how CRC screening uptake can achieve the uptake rates of breast and 114 
cervical screening. 115 
 116 
METHODS 117 
Participants and recruitment strategy 118 
This study was conducted alongside a quantitative study exploring cancer screening uptake 119 
among women living in Glasgow, Scotland. Data on screening participation for the breast, 120 
cervical and CRC screening programmes were linked for all women aged 20 to 74 (n=430,591) 121 
who were registered with NHS Greater Glasgow and Clyde Health Board and invited to 122 
screening during the period 2009 to 2013. This linked dataset was used as a sampling frame 123 
for the present study to select women who were eligible for breast, cervical and CRC screening 124 
6
(n=68,324). Because we expected screening experiences to differ by screening history and on 125 
socioeconomic position we aimed to interview women in each of six groups (Table 2).  126 
Table 2 
Sampling frame 
 
 
 Screening behaviour  
  
Screening participants 
(screened for breast, 
cervical and CRC) 
 
CRC specific non-participants 
(screened for breast and 
cervical, but not CRC)  
Non-participants 
(not screened for breast, 
cervical or CRC) 
Living in    
Most 
socioeconomically 
deprived areas (SIMDa 
quintiles 1-2) 
Invited = 119 
Expressed interest = 13 
Interviewed = 11  
Response rate = 10·92% 
Invited = 244  
Expressed interest = 13 
Interviewed = 9 
Response rate = 5·33% 
Invited = 1,611 
Expressed interest = 14 
Interviewed = 10 
Response rate = 0·87% 
Least 
socioeconomically 
deprived areas (SIMDa 
quintiles 4-5) 
Invited = 20 
Expressed interest = 11 
Interviewed = 10 
Response rate= 55·00% 
Invited = 159 
Expressed interest = 14 
Interviewed = 9 
Response rate = 8·81% 
Invited = 771 
Expressed interest = 13 
Interviewed = 10 
Response rate = 1·69% 
aScottish Index of Multiple Deprivation 
 127 
Purposive sampling was used to randomly identify and invite to interview women with three 128 
different screening histories: i) women who participated in all programmes (screening 129 
participants); ii) women who participated in breast and cervical but not colorectal 130 
programmes (CRC-specific non-participants); and iii) women who participated in none (non-131 
participants). The sample was also stratified to obtain a mix of women from areas of high or 132 
low socioeconomic deprivation (Table 2). Socioeconomic deprivation was indexed by the 133 
Scottish Index of Multiple Deprivation (SIMD), an area-based measure of multiple deprivation 134 
linked to each individual’s home address.[18] The aim was to obtain approximately ten 135 
interviews across the six stratified groups (Table 2). It was anticipated that recruiting non-136 
participants and women living in deprived areas would be more challenging.[19] To ensure 137 
we achieved equal numbers of participants across the six groups we significantly over-138 
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sampled non-participants and women living in deprived areas. In total, 2,924 women were 139 
invited (Table 2). 140 
 141 
The research team provided the Glasgow Clinical Research Facility with the sampling frame to 142 
identify 2,924 women of the 68,324 eligible for all three screening tests to be sent invitation 143 
packs. Invitation packs contained a letter inviting women to participate in a study exploring 144 
views on bowel, breast and cervical cancer screening, a participant information sheet, and a 145 
response form with options to indicate interest by email, phone or using a pre-paid envelope 146 
enclosed. Participants were offered £20 for participation and to cover the cost of 147 
refreshments and travel to the interview. Only women responding to the invitation pack were 148 
subsequently identified to the research team. Ethical approval was obtained from the NHS 149 
Health Research Authority (NRES Committee North West – Liverpool Central, REC reference: 150 
4/NW/1300). 151 
 152 
Interview procedure and materials 153 
The interviewer (MK) met with respondents at locations of their choice: home (n = 35), the 154 
University Of Glasgow (n = 15), work (n=3), community centre (n=5), a parish house (n=1). MK 155 
had spoken to the participants by phone prior to the interview, but had no relationship with 156 
them otherwise. MK is female and had previous experience of conducting interviews and 157 
focus groups with women about cancer screening. All participants provided informed consent 158 
before the semi-structured interview started. The interview followed a topic guide and began 159 
with an open question, ‘What comes to mind when you think about cancer?’ This was followed 160 
in turn with questions on what comes to mind in relation to bowel, breast and cervical 161 
cancers. The next question asked how they felt about their chances of developing breast, 162 
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cervical or CRC. Participants were then asked for their thoughts and feelings about cancer 163 
screening. The interviewer asked, ‘What comes to mind when you think about bowel cancer 164 
screening?’ with supplementary questions on their understanding of what the test involves 165 
and the purpose. This was followed by the same questions in relation to breast and cervical 166 
screening. Finally, participants were shown example invitation letters and leaflets and were 167 
asked how they felt when they received these and how they decided what to do next. The 168 
interviews took place between November 2015 and April 2016, were an average length of 43 169 
minutes, audio recorded and transcribed verbatim.  170 
Analysis 171 
The transcripts were analysed using the Framework Method, which takes a matrix based 172 
analytic approach to facilitate rigorous and transparent data management.[20] This approach 173 
permitted comparisons of accounts between women with different screening histories and 174 
living in different socioeconomic circumstances. 175 
MK, KR and SM read and re-read the data. A mind-mapping process was developed based on 176 
the one-sheet-of-paper method.[21] From these mind maps, MK identified themes as the 177 
basis of the framework matrix. The themes were organised into the three MAP routes: 178 
motivation; action-on-motivation; and prompts.[17] As described by Ritchie and 179 
colleagues,[20] the framework matrix was organised in a MS Excel spreadsheet containing 180 
one theme per worksheet with sub-themes in the columns. The rows contained individual 181 
participants, grouped by screening history and socioeconomic status. The themes and sub-182 
themes within the framework matrix were discussed within the research team. Two 183 
researchers (MK and LG) coded the transcript in full and populated the framework matrix with 184 
relevant data extracts. They discussed comments and queries using web-based collaboration 185 
software (Trello), thus creating an audit trail. MK summarised each theme by comparing 186 
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patterns within the pre-identified participant categories (screening history and socioeconomic 187 
status) and noting representative data extracts. KR reviewed and discussed the summaries 188 
with MK to ensure consistency with the data. 189 
RESULTS 190 
Sample characteristics 191 
Of the 2,924 women sent an invitation to participate; 2,629 did not respond, 129 declined, 76 192 
invitations were returned undelivered, four women had died, and 86 expressed an interest in 193 
being interviewed of which four were excluded (due to becoming uncontactable, residing 194 
primarily outside the UK, or having a stoma). In total, 61 interviews were scheduled and 59 195 
women were interviewed.  196 
Response rates varied considerably across the six groups; 55% of people who had participated 197 
in all three programmes, and who lived in the least deprived areas agreed to be interviewed, 198 
whereas only 0.9% of people who had participated in none of the programmes and lived in 199 
the most deprived areas agreed to be interviewed (Table 2). The respondents’ age ranged 200 
from 51 to 64 years. The respondents’ views varied most commonly by screening participation 201 
history (screening participants, CRC-specific non-participants, non-participants), which 202 
formed our main comparison category. Comparisons by socioeconomic deprivation did not 203 
show clear differences in respondents’ views but are highlighted where differences were 204 
found. 205 
The results were organised into the three routes of behaviour change described by the MAP 206 
approach: motivational challenges to CRC screening; action-on-motivation challenges to CRC 207 
screening; and prompts to CRC screening.[17, 22]. The results are summarised in Table 3.  208 
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Table 3 
Summary of results identifying unique challenges to colorectal cancer screening in comparison to breast and cervical screening 
 
 Screening behaviour 
 Screening participants 
(screened for breast, cervical and CRC) 
 
CRC specific non-participants  
(screened for breast and cervical, but not CRC) 
Non-participants 
(not screened for breast, cervical or CRC) 
Motivational challenges to colorectal screening 
 
Treatment beliefs Less negative view of treatment than in other two 
groups 
 
CRC treatment perceived as more severe than 
breast or cervical 
Treatment most threatening aspect of cancer 
Beliefs about the value 
of screening  
 
Valued screening Some questioned value of CRC screening and 
self-sampling reduced credibility 
Questioned value as intolerable cancer 
treatment would still be necessary 
Disgust and 
embarrassment 
 
Acknowledged but overcome Frequently discussed as barriers, avoided 
talking about CRC screening with others 
Frequently discussed as barriers 
Symptom beliefs Acknowledged screening is for asymptomatic as 
more treatable at earlier stage of diagnosis 
Screening to check existing symptoms, CRC 
symptoms more visible and detectable 
reducing need for CRC screening 
 
Screening to check existing symptoms, 
therefore unnecessary in the absence of 
symptoms 
Comorbidities and 
previous colorectal 
investigations 
 
Comorbidities mentioned less frequently Felt less need for CRC screening because of 
previous colorectal investigations 
Psychological and physical comorbidities made 
less willing to screen 
Action-on-motivation challenges to colorectal screening 
 
Lack of health 
professional 
involvement 
Acknowledged CRC self-sampling was awkward, 
but overcome 
Worried about completing FOBt incorrectly, 
CRC burdensome and complicated, 
disengagement from process possible for 
breast and cervical but not CRC 
 
Worried about completing FOBt incorrectly, 
CRC burdensome and complicated 
Colorectal screening 
requires planning 
 
Detailed planning  Rarely described making plans to screen  Rarely described making plans to screen 
Comorbidities Comorbidities mentioned less frequently Comorbidities impediments to CRC self-
completion 
Comorbidities impediments to CRC self-
completion and to a lesser extent breast and 
cervical screening 
 
Prompts to colorectal screening 
 
Postponing and 
forgetting 
 
Described using prompts to avoid forgetting Lack of appointment time or deadline made 
CRC more easily delayed or forgotten 
Lack of appointment time or deadline made 
CRC more easily delayed or forgotten 
209 
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 Motivational challenges to CRC screening 210 
Treatment beliefs 211 
CRC-specific non-participants considered CRC treatment to be more severe than breast or 212 
cervical cancer treatment.  213 
“I know that breast cancer caught early is really treatable. {…} I think cervical 214 
cancer’s totally curable. {…} I don’t really know that much about the bowel one. I 215 
mean, I know that bowel cancer’s very, very serious. I mean, you can live without 216 
your breasts, you know, you can, you know, have a hysterectomy {…} you cannae 217 
[cannot] really live without the bowels “ (P134, 53 years, CRC-specific non-218 
participant) 219 
Similarly, for non-participants the most threatening aspect of cancer appeared to be its 220 
treatment. They questioned the effectiveness of cancer treatments to reduce mortality and 221 
expressed concern over side effects, such as hair loss, nausea, fatigue, and the quality of life 222 
that patients experienced during and after treatment. These respondents questioned 223 
whether they would accept treatment if they were diagnosed with cancer. Further, non-224 
participants, mostly from those living in the least deprived areas, did not believe early 225 
detection could help them avoid cancer treatments that would reduce their quality of life.  226 
“you just don’t want to think of bowel cancer, and getting colostomies or 227 
whatever. Just the very thought. Sometimes I think I’d rather just not know and 228 
die, rather than be diagnosed with that and having a colostomy. {…} I would rather 229 
just die than go about like that, that’s not living” (P45, 64 years, non-participant) 230 
In contrast, the screening participants viewed cancer treatment more positively. 231 
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 “If you are unlucky enough and you lose the whole bowel and you have to have 232 
a colostomy bag then are you not better having that than dying?” (P58, 59 years, 233 
screening participant) 234 
Beliefs about the value of CRC screening 235 
CRC-specific non-participants questioned the value of CRC screening. These respondents 236 
doubted the efficacy of FOBt after having heard of others who had false negative FOBt results. 237 
They also believed that self-sampling reduced the credibility of CRC screening and completing 238 
the test in their own bathrooms seemed incongruent with the respondents’ schemata for 239 
medical tests. 240 
“if somebody [in health care team] had said … you know, “Come along and sit on 241 
the toilet and we’ll collect your poo,” somehow it would have felt a little bit more 242 
detached, a little bit more kind of clinical {…} they’d probably have worked out 243 
some sort of system that they can do that more easily without needing plastic 244 
bags and God knows what else” (P121, 53 years, CRC-specific non-participant) 245 
Disgust and embarrassment 246 
The only test described as disgusting was FOBt. CRC-specific and non-participants spoke about 247 
disgust more often than screening participants. Participants’ disgust related to FOBt being a 248 
self-completed test, the involvement of faeces and its association with bowel functions. In 249 
each group, participants described CRC screening to be embarrassing, with embarrassment 250 
relating to handling their faeces, storing the test kit and concern about other people (such as 251 
grandchildren) finding the FOBt kit, or postal workers having to handle the envelopes 252 
containing completed kits. Breast and cervical screening were perceived to be more 253 
acceptable and easier to discuss than CRC screening. 254 
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 “you would think getting your tits out or, you know, opening your legs for some 255 
speculum, you would feel as though both of those things ought to be more 256 
intimate [laughs] but actually, I think it’s probably because the way that we are 257 
brought up not to discuss bowels in this country” (P95, 55 years, CRC-specific non-258 
participant) 259 
CRC-specific non-participants reported talking about cancer screening less often and 260 
specifically avoided talking about CRC screening, which respondents living in more deprived 261 
areas reported as off-limits for discussion. Respondents tended to describe talking about FOBt 262 
as immature, likening it to children laughing about “farts and smells” (P121, 53 years, CRC-263 
specific non-participant).  264 
“you’re told when you’re young [laughs] not tae talk about stuff like that {…} 265 
except for when you’re a boy when all bodily functions are, you know, extremely 266 
funny in your mind” (P134, 53 years, CRC-specific non-participant) 267 
Symptom beliefs 268 
A theme among CRC-specific and non-participants was that they felt they would be 269 
better able to detect CRC symptoms, like indigestion or blood in their faeces than breast 270 
or cervical cancer symptoms. Similarly, non-participants also reported that they would 271 
‘know’ if they had cancer making screening unnecessary, particularly in the absence of 272 
symptoms.  273 
“it [smear test] picks up any issues if you’re not aware of issues {…} I think the 274 
bowel cancer one, you kind of know, most people know what the symptoms would 275 
be and therefore you assume that if you – since it’s easy to see, that you’re okay 276 
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 {…} ‘cos you’re not aware of any symptoms.” (P165, 54 years, CRC-specific non-277 
participant) 278 
Screening participants believed that by the time cancer caused symptoms it would be 279 
advanced and less treatable. In contrast to CRC-specific and non-participants, screening 280 
participants thought they would have difficulty detecting CRC without FOBt. 281 
Comorbidities and previous colorectal investigations 282 
Some CRC-specific non-participants reported having had colorectal investigations and 283 
therefore felt less need for bowel screening. Non-participants also described how 284 
psychological and physical comorbidities made them less willing to complete screening. 285 
Physical comorbidities meant participants felt unable to cope with the prospect of additional 286 
investigations and/or treatment. Anxiety prevented some non-participants from deciding for 287 
or against cancer screening. A few reported depressive symptoms and thoughts of suicide; in 288 
this context cancer seemed to be an ‘easier’ (or, at least, a blameless) way to die—negating 289 
any perceived need for cancer screening. 290 
Action-on motivation challenges to CRC screening 291 
Lack of health professional involvement 292 
CRC-specific non-participants and non-participants expressed worry about completing FOBt 293 
incorrectly without the support of a health professional. This set CRC screening apart from 294 
breast or cervical screening where health professionals conduct the tests. 295 
“I suppose it’s different, it’s like a self-kit, you know? … compared to the other two 296 
are being done by professionals. That’s their job and maybe you just feel like 297 
they’re doing it right.” (P150, 54 years, CRC-specific non-participant) 298 
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 To complete FOBt correctly, CRC-specific non-participants felt they needed to be fully 299 
engaged and ‘pay attention’. In contrast, with breast and cervical screening they could 300 
disengage to some extent as the health professional completed these tests for them.  301 
“When you go and get a cervical screen you don’t have to do anything, you just 302 
turn up. For bowel screening, you’ve got to go that extra step. {…} you’ve actually 303 
to make the effort to do it and collect the sample and seal it up and all whatever, 304 
and send it away.” (P165, 54 years, CRC-specific non-participant) 305 
CRC-specific non-participants described using disengagement during breast or cervical 306 
screening to cope with physical or psychological discomfort, but disengagement to overcome 307 
disgust or displeasure was not possible with self-completed CRC screening.  308 
CRC-specific non-participants and non-participants reported CRC screening to be 309 
burdensome. Having to read instructions was considered to be a “hurdle” (P165, 54 years, 310 
CRC-specific non-participant) and FOBt to be complicated and effortful. Having to take three 311 
samples added to FOBt seeming burdensome. In contrast, screening participants rarely 312 
reported that FOBt was time consuming or complicated, but they agreed that taking faecal 313 
samples by themselves was awkward to do. 314 
“If somebody was to {…} make it [FOBt] easy for me, I would have done it because 315 
I approve of the principle” (P166, 57 years, CRC-specific non-participant) 316 
CRC screening requires planning 317 
CRC-specific and non-participants rarely described making plans to do screening. In contrast, 318 
screening participants described detailed planning strategies to overcome practical barriers. 319 
They reported dealing with CRC screening invitations promptly and planned specific days to 320 
do the FOBt. Screening participants living in the least deprived areas also described routines 321 
16
 for cleaning after FOBt completion and using gloves and wipes to make FOBt less disgusting 322 
to them.  323 
Impact of comorbidities 324 
Illnesses and other conditions were an additional challenge to the self-completion of FOBt. 325 
Non-participants most often reported unpredictable bowel movements, diarrhoea, IBS, 326 
coeliac disease, multiple sclerosis and other health conditions as impediments to CRC 327 
screening although such conditions were also mentioned by CRC-specific non-respondents. A 328 
further two respondents with visual impairments reported abandoning half-completed FOBt 329 
kits or waiting for a support worker to organise help with doing FOBt. 330 
“I’ve got coeliacs, so, it’s very, very seldom my bowel, my my my toilet is... what’s 331 
the word? Solid. {…} so it’s quite difficult that way. So, maybe once I get the 332 
coeliacs and everything under control then it might be different” (P130, 54 years, 333 
CRC-specific non-participant) 334 
Prompts to CRC screening 335 
Postponing and forgetting 336 
Unlike breast and cervical screening, CRC screening is completed at home and does not 337 
require an appointed time. CRC-specific and non-participants reported that CRC 338 
screening could be more easily delayed or forgotten than cervical screening which only 339 
required them to make an appointment, and even more easily than breast screening 340 
where the appointment is pre-arranged. Some CRC-specific non-participants and non-341 
participants living in the least deprived areas explained that they would put their FOBt 342 
invitation to one side and, as a result, forget about it.  343 
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 “if it’s a bowel screening one, yep, put it somewhere and think ‘Yes, I’ll do that’ 344 
and then forget about it because it doesn’t have an appointment date. I think if 345 
something has an appointment date, you’re forced to act.” (P165, 54 years, CRC-346 
specific non-participant) 347 
Screening participants living in the least deprived areas described creating CRC screening 348 
reminders: leaving the FOBt material near their bathroom or within their view as a cue. 349 
“I just usually take the pack, read the instructions again leave it in the loo until the 350 
next time I have to go {…} I just usually take all the bits in and just leave them there 351 
to remind me what I’ve to do” (P172, 57 years, screening participant) 352 
DISCUSSION 353 
Our findings show that women who participated in breast and cervical but not CRC screening 354 
(CRC-specific non-participants) differed in their barriers to CRC screening compared to 355 
screening participants and to a lesser extent, non-participants. CRC-specific non-participants 356 
reported that treatment for CRC was more severe than for breast or cervical cancer, and 357 
colorectal symptoms were easier to detect oneself than breast or cervical symptoms, which 358 
influenced their motivation to complete CRC screening. CRC-specific non-participants also 359 
worried about incorrectly completing the test without the support of a health professional, 360 
and that they felt the home-based CRC screening test could be more easily delayed or 361 
forgotten than breast or cervical screening, which challenged the translation of their 362 
motivation into action.[16] 363 
 364 
A key strength of our study was in achieving a sample of women whose screening histories 365 
were objectively established by linking three cancer screening programmes’ data for the 366 
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 entire population of Glasgow, Scotland. To our knowledge, this has not previously been done. 367 
Among the CRC-specific non-participants and the non-participants the response rate to the 368 
invitations to be interviewed was extremely low (0.9-5.3%) reflecting the difficulty of engaging 369 
all population groups in research, and the value of the data that has been obtained. The study 370 
has limitations; the SIMD measure used to assess socioeconomic deprivation was an area-371 
based measure which offers a relatively blunt assessment and may offer one explanation for 372 
the limited number of socioeconomic deprivation differences noted in the analysis. The study 373 
focused on women due to the design, and so it is yet to be determined if the same specific 374 
CRC challenges apply to men. It is also noted that this study focused on increasing uptake of 375 
CRC and does not consider explicitly the role of informed choice principles. Some women 376 
make an informed choice not to engage in cancer screening which is entirely appropriate.[23] 377 
Our approach does not conflict with the principles of informed choice. For example providing 378 
more information reflecting advances in colorectal cancer treatment would increase 379 
knowledge.[24] However, interventions to address the identified motivational challenges 380 
would aim to improve knowledge and understanding and so support informed choice. The 381 
action-on-motivation targets would be aimed at supporting people who intend to screen to 382 
put their intentions into action and so would not compromise informed choice. 383 
 384 
Understanding why CRC screening fails to achieve the uptake rates of breast and cervical has 385 
been explored in one previous self-report, survey study.[15] We are able to expand on the 386 
survey’s results, as our findings explain that screening participants also dislike the self-387 
completed FOBt, but manage these feelings; our findings show that medical reasons to for 388 
non-participation in CRC screening can include comorbidities that impede self-completed CRC 389 
screening, but also that women with previous colorectal investigations feel less need for CRC 390 
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 screening. Other studies have considered the relatively low uptake of CRC in isolation, and 391 
while they have identified similar barriers to the present study around, for example, fears 392 
about treatment, being asymptomatic, concerns about self-completion[8-11] etc., the present 393 
study adds a more nuanced understanding, which informs potential targets for future 394 
interventions to increase CRC screening uptake. While it is acknowledged that people are 395 
fearful of cancer treatment,[11, 25] the present study identified that women fear of 396 
treatments for CRC more than breast or cervical cancer, which may partly explain their 397 
reluctance to engage in CRC screening. Similarly, being asymptomatic is a commonly 398 
recognised barrier in the screening literature.[8, 26] Surveys have established that awareness 399 
of CRC symptoms is low,[27] but it was previously unknown that there may be a 400 
misunderstanding that colorectal symptoms are more easily self-detected than breast and 401 
cervical symptoms. Furthermore, the present study has illustrated the unique challenges of 402 
self-completion of CRC screening in the absence of a health professional, and the greater 403 
chance of procrastinating or forgetting the test in the absence of a specified appointment 404 
time. We note that similar barriers have been identified for Human Papillomavirus self-405 
sampling for cervical screening.[28, 29] 406 
 407 
We have identified potential targets for interventions to increase CRC screening uptake and 408 
drafted example policy recommendations (Table 4). For example, to reduce fear and 409 
misconceptions of CRC treatments, we recommend a concerted information campaign 410 
reflecting advances in CRC treatment and success stories.[30] To increase awareness that CRC 411 
screening is for people who are asymptomatic, we recommend a concerted information 412 
campaign to reiterate and reinforce existing messages that CRC screening is for the 413 
asymptomatic, and symptoms may only appear at an advanced stage. To reduce postponing 414 
20
 and forgetting, we recommend providing a further reminder and potentially a suggested 415 
deadline for kit return. It is important to note that Scotland replaced FOBt bowel screening 416 
with Faecal Immunochemical Testing (FIT) in November 2017 and FIT will be introduced in 417 
England and Wales in 2019. FIT requires only one faecal sample and, based on evidence from 418 
pilot studies[31] and the initial months since its introduction in Scotland,[32] it is likely this 419 
easier to complete test will increase uptake. Nonetheless, FIT alone is not sufficient to address 420 
the other identified challenges to CRC screening uptake, and complementary interventions 421 
are recommended. 422 
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  423 
Table 4 
Potential targets to increase colorectal cancer screening 
 
Challenges to successful 
colorectal cancer screening 
Potential targets to 
increase CRC screening 
uptake 
 
Example policy recommendation 
Motivational challenges to 
colorectal screening 
 
  
Treatment beliefs Reduce fear and 
misconceptions of 
colorectal cancer 
treatments 
 
Concerted information campaign reflecting 
advances in colorectal cancer treatment and 
success stories 
Beliefs about the value of 
screening  
Increase credibility of self-
sample test 
Concerted information campaign emphasising 
value of the self-sample test 
 
Disgust and 
embarrassment 
Reduce disgust and 
embarrassment 
Concerted information campaign modelling 
people talking about the test to support 
positive social norms 
 
Symptom beliefs Increase awareness that 
colorectal screening for 
asymptomatic 
 
Concerted information campaign reiterating 
that colorectal screening for asymptomatic 
Comorbidities and 
previous colorectal 
investigations 
 
Increase support for those 
with other health priorities 
Increase awareness within primary care to 
provide support for colorectal screening 
among people with other health conditions  
Action-on-motivation 
challenges to colorectal 
screening 
 
  
Lack of health professional 
involvement 
Increase people’s 
confidence to self-complete 
the test correctly 
 
Provide examples of others’ experiences of 
completing the self-sample test to model 
successful completion 
Colorectal screening 
requires planning 
Increase people’s ability to 
plan how, when and where 
they will complete their 
test 
 
Provide planning support tool with the self-
sample test 
Comorbidities Increase support for those 
with other health priorities 
Increase awareness within primary care to 
provide support for colorectal screening 
among people with other health conditions  
 
Prompts to colorectal 
screening 
 
  
Postponing and forgetting Increase prompts to avoid 
postponing and forgetting 
 
Provide further reminders 
Provide a suggested deadline for kit return 
 424 
This study represents the first step in a process by identifying potential targets to increase 425 
CRC screening uptake.[22] It will be necessary to test in a randomised controlled trial whether 426 
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 an intervention strategy increases uptake by affecting the specified targets.[22] This 427 
systematic approach is in line with current best practice guidance on the development of 428 
complex interventions,[33, 34] and will build on and expand existing knowledge of effective 429 
strategies to improve cancer screening uptake.[35]  430 
 431 
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